Cargando…
Cardiovascular Disease in the COVID-19 Era: Myocardial Injury and Thrombosis
COVID-19 is now appreciated as a pandemic, presenting with a wide range of symptoms, mostly respiratory, yet involving other organs massively. Myocardial injury is a crucial complication with significant negative impact on prognosis. Despite all the investigations, exact pathophysiologic mechanisms...
Autores principales: | Amin, Ahmad, Sadeghipour, Parham, Chitsazan, Mitra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893250/ http://dx.doi.org/10.1016/B978-0-323-80915-3.00044-2 |
Ejemplares similares
-
Cardiovascular Complications of COVID-19: Pharmacotherapy Perspective
por: Talasaz, Azita Hajhossein, et al.
Publicado: (2020) -
CORONARY THROMBOSIS AND MYOCARDIAL INJURY IN A COVID 19 PATIENT
por: Quiroga, Mercedes, et al.
Publicado: (2021) -
Heart failure with preserved ejection fraction in coronavirus disease 2019 patients: the promising role of diuretic therapy in critically ill patients
por: Chitsazan, Mitra, et al.
Publicado: (2021) -
Metabolic Syndrome is Associated With Higher Wall Motion Score and Larger Infarct Size After Acute Myocardial Infarction
por: Hajsadeghi, Shokoufeh, et al.
Publicado: (2015) -
Effects of triiodothyronine replacement therapy in patients with chronic stable heart failure and low‐triiodothyronine syndrome: a randomized, double‐blind, placebo‐controlled study
por: Amin, Ahmad, et al.
Publicado: (2015)